On May 26, 2023, Titan Medical announced a significant milestone in its business operations. The company has entered into a license agreement with Intuitive Surgical, a renowned global leader in minimally invasive care and the pioneer of robotic-assisted surgery. As part of the agreement, Intuitive Surgical will pay an upfront fee of $7.5 million to Titan Medical for certain intellectual property.
The license agreement grants Intuitive Surgical a non-exclusive license to all of Titan’s intellectual property, with the exception of the intellectual property that is exclusively licensed to another party under a license agreement signed in June 2020. Despite the licensing, Titan Medical retains ownership of the licensed intellectual property, along with the associated rights, including the right to continue developing and commercializing the technologies covered by the licensed intellectual property.
This agreement is a significant win for Titan Medical, a surgical robotics developer, as it provides the company with a substantial financial boost and expands its reach in the industry. It also highlights the quality of Titan Medical’s intellectual property and the potential for future growth and innovation.
Intuitive Surgical Inc. (ISRG) – A Promising Investment Opportunity in Health Technology Sector
On May 26, 2023, Intuitive Surgical Inc. (ISRG) opened at 304.41 and closed at 304.12, down 0.61 points or 0.20%. However, the company’s market cap is valued at $109.9 billion, and its earnings growth for this year is projected to be 17.02%. ISRG operates in the health technology sector, specifically in medical specialties, and focuses on developing and manufacturing robotic-assisted surgical systems. In terms of financials, ISRG reported annual revenue of $6.2 billion and a net profit margin of 21.25% in the last fiscal year. ISRG’s current P/E ratio is 83.8, which is higher than the industry average of 42.2. Its price/sales ratio is 15.44, and its price/book ratio is 9.94. ISRG’s next reporting date is on July 20, 2023, with an EPS forecast of $1.33 for this quarter. Overall, ISRG’s strong financials and promising growth projections suggest that it may be a good investment opportunity in the health technology sector.
Intuitive Surgical Inc.: A Leading Manufacturer of Surgical Robots with Strong Financial Performance and Innovative Technology
Intuitive Surgical Inc. (ISRG) is a leading manufacturer of surgical robots used in minimally invasive surgeries. The company has been growing impressively and maintaining a steady growth trajectory despite the challenges posed by the pandemic. According to CNN Money, the 20 analysts offering 12-month price forecasts for ISRG have a median target of $314.50, indicating a 2.83% increase from the last price of $305.83. The current consensus among 26 polled investment analysts is to buy stock in Intuitive Surgical Inc. The company’s strong financial performance and innovative technology have made it an attractive investment opportunity for investors.
Discussion about this post